The Stock has YTD (year to date) performance of -59.38 percent.
Several other equities research analysts also recently weighed in on ENDP. Endo International PLC now has a consensus rating of Hold and a consensus target price of $11.67. ValuEngine cut Endo International PLC from a "buy" rating to a "hold" rating in a report on Friday, September 1st.
Shares of Endo Int'l Plc (NASDAQ:ENDP) now have an Average Brokerage Recommendation of 2.57, number of Recs in ABR is 14 while industry rank of the company by ABR is out of 265. The company now has an average rating of "Hold" and an average target price of $11.67.
Shares of Endo International PLC (NASDAQ:ENDP) traded up $0.84 during mid-day trading on Friday, reaching $6.93. 12,136,900 shares of the company's stock were exchanged, compared to its average volume of 7,342,927. The stock touched 52-week High of $18.63 on 11/15/16 and 52-week Low of $5.77 on 10/27/17. The Beta for the company stands at 0.53 and its Average True Range (ATR) shows a value of 0.53. During current year the company's forecasts over growth are -22.8% while for the next year analysts' growth estimation is -17.8%.
Endo International PLC (NASDAQ:ENDP) (TSE:ENL) last issued its earnings results on Thursday, November 9th. As of the latest earnings report the EPS was $-19.47 with 222.96M shares now outstanding.
While having a peek at profitability ratios Endo Int'l Plc (NASDAQ:ENDP) has trailing twelve month gross margin at 37.6%, its trailing twelve month operating margin stands at -99.1% whereas its trailing twelve month net profit margin spots at 0%. EPS long term mean growth rate estimated by 2 analysts is at -6.3%, whereas, the high and low Long term growth rate estimated at 4 and -16.61. This means that over the past quarter there has been an increase of insiders buying their shares of ENDP in relation to earlier this year.
Endo International PLC (NASDAQ:ENDP) (TSE:ENL) had its price objective lowered by research analysts at Citigroup Inc. from $9.00 to $7.00 in a report released on Friday.
Foundry Partners LLC Acquires New Stake in Cisco Systems, Inc. (CSCO)
Also, SVP Karen Walker sold 23,110 shares of the firm's stock in a transaction on Wednesday, September 13th. After a recent spot-check, the stock has touched $34.13 which represents a change from the open of 0.81%.
TRADEMARK VIOLATION WARNING: This piece was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another site, it was stolen and republished in violation of US and global trademark & copyright law.
Endo International plc (ENDP) has the market capitalization of $1.49 Billion.
In other Endo International PLC news, CFO Blaise Coleman acquired 6,500 shares of the stock in a transaction on Tuesday, August 15th. Amalgamated Bank now owns 32,357 shares of the company's stock valued at $361,000 after buying an additional 619 shares in the last quarter.
The company now has an insider ownership of 0.5 Percent and Institutional ownership of 89.5 Percent. During previous trade 9.92 Million shares of Endo Int'l Plc (NASDAQ:ENDP) exchanged hands whereas on average nearly 6.66 Million shares has been traded. Its investment was valued at $95,123,000 a decrease of $10,665,000 as of the end of the quarter. Teachers Retirement System of The State of Kentucky boosted its stake in shares of Endo International PLC by 30.0% in the first quarter.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of the company stands at 9.69 while the industry's and the sector's growth for next 5 years ticked at 10.12 and 10.32 respectively. Gamco Investors INC. ET AL raised its holdings in shares of Endo International PLC by 76.2% in the third quarter. The firm has a Return on Assets (ROA) value of -38.70%. Alps Advisors Inc. raised its holdings in shares of Endo International PLC by 9.3% in the third quarter. Following the completion of the acquisition, the chief financial officer now owns 13,729 shares in the company, valued at approximately $108,321.81.
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology.
- Dearborn Partners LLC Purchases 9520 Shares of Automatic Data Processing (NYSE:ADP)
- 49ers coach Kyle Shanahan talks about Marquise Goodwin's emotional day
- Fox Sports Accused of Playing Role in Bribing Officials — FIFA Trial
- Kansas vs Kentucky, K-State vs UMKC, Wichita State a victor
- Rochester mom admits to drowning infant son
- I&B curtain falls on Nude, S Durga
- Potential boost for Newcastle over Luke Shaw as Manchester United identify replacement
- Multiple reports: Randolph megasite a finalist for Toyota-Mazda plant
- Denmark claim last European spot at World Cup after thrashing Ireland
- Earnings Prediction Review: Henry Schein, Inc. (HSIC)